106 related articles for article (PubMed ID: 20694902)
1. The ethical urgency of advancing implementation science.
Solomon MZ
Am J Bioeth; 2010 Aug; 10(8):31-2. PubMed ID: 20694902
[No Abstract] [Full Text] [Related]
2. Ethical analysis of translational research is more complex than distinguishing T1 from T2.
Allen B
Am J Bioeth; 2010 Aug; 10(8):33-5. PubMed ID: 20694903
[No Abstract] [Full Text] [Related]
3. Diverse ethics of translational research in the developing world.
Lang T
Am J Bioeth; 2010 Aug; 10(8):41-2. PubMed ID: 20694907
[No Abstract] [Full Text] [Related]
4. Translational research beyond approval: a two-stage ethics review.
Sofaer N; Eyal N
Am J Bioeth; 2010 Aug; 10(8):W1-3. PubMed ID: 20694895
[No Abstract] [Full Text] [Related]
5. The diverse ethics of translational research.
Sofaer N; Eyal N
Am J Bioeth; 2010 Aug; 10(8):19-30. PubMed ID: 20694901
[TBL] [Abstract][Full Text] [Related]
6. Impediments to "T2" research: are ethics really to blame?
Lipworth W; Kerridge I
Am J Bioeth; 2010 Aug; 10(8):39-40. PubMed ID: 20694906
[No Abstract] [Full Text] [Related]
7. Traveling across borders--the pitfalls of clinical trial regulation and stem cell exceptionalism.
Hauskeller C; Wilson-Kovacs D
Am J Bioeth; 2010 May; 10(5):38-40. PubMed ID: 20461647
[No Abstract] [Full Text] [Related]
8. Post-approval translational research itself has diverse ethics.
Mukherjee J
Am J Bioeth; 2010 Aug; 10(8):43-4. PubMed ID: 20694908
[No Abstract] [Full Text] [Related]
9. Clinical placebo interventions are unethical, unnecessary, and unprofessional.
Hróbjartsson A
J Clin Ethics; 2008; 19(1):66-9. PubMed ID: 18552056
[No Abstract] [Full Text] [Related]
10. FDA. Proposed guidelines for emergency research aim to quell confusion.
Couzin J
Science; 2006 Sep; 313(5792):1372-3. PubMed ID: 16959979
[No Abstract] [Full Text] [Related]
11. [Clinical trials: vulnerability and ethical relativism].
Lima C
Acta Med Port; 2005; 18(3):221-6. PubMed ID: 16207458
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic obligation in clinical research.
Weijer C; Miller PB
Hastings Cent Rep; 2003; 33(3):3. PubMed ID: 12854444
[No Abstract] [Full Text] [Related]
13. The historical and moral imperatives of comparative effectiveness research.
Lauer MS
Stat Med; 2010 Aug; 29(19):1982-4; discussion 1996-7. PubMed ID: 20683887
[No Abstract] [Full Text] [Related]
14. Varieties of standard-of-care treatment randomized trials: ethical implications.
Kim SY; Miller FG
JAMA; 2015 Mar; 313(9):895-6. PubMed ID: 25591061
[No Abstract] [Full Text] [Related]
15. The challenge of assuring continued post-trial access to beneficial treatment.
Grady C
Yale J Health Policy Law Ethics; 2005; 5(1):425-35. PubMed ID: 15742586
[No Abstract] [Full Text] [Related]
16. Is risky pediatric research without prospect of direct benefit ever justified?
Martin RA; Robert JS
Am J Bioeth; 2007 Mar; 7(3):12-5. PubMed ID: 17366221
[No Abstract] [Full Text] [Related]
17. International codes of research ethics: current controversies and the future.
Levine RJ
Indiana Law Rev; 2002; 35(2):557-67. PubMed ID: 16189916
[No Abstract] [Full Text] [Related]
18. Lessons from the ARDS network ventilator trial design controversy.
Shanawani H
Respir Care Clin N Am; 2004 Sep; 10(3):317-28, vi. PubMed ID: 15458730
[TBL] [Abstract][Full Text] [Related]
19. Improving the decision processes of institutional review boards.
Wagner TH
JAMA; 2004 Apr; 291(14):1698; author reply 1698-9. PubMed ID: 15082694
[No Abstract] [Full Text] [Related]
20. Attracting attention: right or wrong.
Robichaud A
Am J Bioeth; 2010 Sep; 10(9):66-7. PubMed ID: 20818569
[No Abstract] [Full Text] [Related]
[Next] [New Search]
